Stonepine Capital Management as of Sept. 30, 2024
Portfolio Holdings for Stonepine Capital Management
Stonepine Capital Management holds 38 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Adma Biologics (ADMA) | 23.6 | $37M | 1.9M | 19.99 | |
| Evolus (EOLS) | 14.0 | $22M | 1.4M | 16.20 | |
| Galapagos Nv Spon Adr (GLPG) | 8.7 | $14M | 479k | 28.79 | |
| Jazz Pharmaceuticals Plc Us Listed Shs Usd (JAZZ) | 3.9 | $6.1M | 55k | 111.41 | |
| Royalty Pharma Shs Class A (RPRX) | 3.8 | $6.0M | 212k | 28.29 | |
| Xoma Corp Com New (XOMA) | 3.3 | $5.2M | 195k | 26.48 | |
| Rigel Pharmaceuticals (RIGL) | 3.2 | $5.0M | 309k | 16.18 | |
| Zevra Therapeutics Com New (ZVRA) | 3.1 | $4.9M | 700k | 6.94 | |
| Anika Therapeutics (ANIK) | 3.0 | $4.7M | 189k | 24.70 | |
| Revance Therapeutics (RVNC) | 2.7 | $4.3M | 820k | 5.19 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 2.6 | $4.1M | 1.0M | 4.12 | |
| Verastem Com New (VSTM) | 2.5 | $3.9M | 1.3M | 2.99 | |
| Optinose (OPTN) | 2.4 | $3.8M | 5.7M | 0.67 | |
| Urogen Pharma (URGN) | 2.2 | $3.6M | 280k | 12.70 | |
| Scpharmaceuticals (SCPH) | 2.2 | $3.6M | 779k | 4.56 | |
| Establishment Labs Holdings Ord (ESTA) | 2.1 | $3.2M | 75k | 43.27 | |
| ACADIA Pharmaceuticals (ACAD) | 1.9 | $3.0M | 197k | 15.38 | |
| Day One Biopharmaceuticals I (DAWN) | 1.8 | $2.9M | 206k | 13.93 | |
| Aclaris Therapeutics (ACRS) | 1.8 | $2.8M | 2.5M | 1.15 | |
| Tela Bio (TELA) | 1.8 | $2.8M | 1.1M | 2.53 | |
| Indivior Ord (INDV) | 1.7 | $2.6M | 270k | 9.75 | |
| Exagen (XGN) | 1.0 | $1.7M | 534k | 3.09 | |
| Milestone Pharmaceuticals (MIST) | 1.0 | $1.5M | 1000k | 1.52 | |
| Surrozen Com New (SRZN) | 0.8 | $1.3M | 110k | 11.98 | |
| Aytu Biopharma (AYTU) | 0.7 | $1.2M | 501k | 2.35 | |
| Kezar Life Sciences | 0.7 | $1.2M | 1.5M | 0.77 | |
| Adicet Bio (ACET) | 0.6 | $878k | 609k | 1.44 | |
| Arcutis Biotherapeutics (ARQT) | 0.5 | $823k | 89k | 9.30 | |
| Paragon 28 (FNA) | 0.5 | $766k | 115k | 6.68 | |
| Kiora Pharmaceuticals (KPRX) | 0.5 | $741k | 202k | 3.66 | |
| Polypid (PYPD) | 0.3 | $477k | 139k | 3.44 | |
| 2seventy Bio Common Stock (TSVT) | 0.3 | $472k | 100k | 4.72 | |
| Myomo Com New (MYO) | 0.3 | $401k | 100k | 4.01 | |
| Aprea Therapeutics Com New (APRE) | 0.2 | $377k | 137k | 2.75 | |
| Iteos Therapeutics (ITOS) | 0.2 | $306k | 30k | 10.21 | |
| Tenax Therapeutics Com New (TENX) | 0.1 | $173k | 50k | 3.46 | |
| Viracta Therapeutics (VIRX) | 0.1 | $116k | 500k | 0.23 | |
| Alimera Sciences Inc Cvr Com New | 0.1 | $96k | 2.4M | 0.04 |
